Malignancy After Kidney Transplantation
By:
John P. Vella Division of Nephrology and Transplantation, Maine Medical Center, and Tufts University School of Medicine, Portland, Maine

Search for other papers by John P. Vella in
Current site
Google Scholar
PubMed Close
and
Alexander C. Wiseman Division of Renal Diseases and Hypertension, Transplant Center, University of Colorado Denver, Aurora, Colorado

Search for other papers by Alexander C. Wiseman in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 18: Issue 5
Published Online:
Nov 2019
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 18: Issue 5 (Nov 2019): Transplantation

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
© American Society of Nephrology 2019
Page Count:
0
Article Category:
Research Article
Print Publication Date:
01 Nov 2019
Published Online:
Nov 2019
  • 1.

    Au E, Wong G, Chapman JR: Cancer in kidney transplant recipients. Nat Rev Nephrol 14: 508–520, 2018 PubMed

  • 2.

    Bhat M, Mara K, Dierkhising R, Watt KDS: Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients. Mayo Clin Proc 93: 1236–1246, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Hellström V, Lorant T, Döhler B, Tufveson G, Enblad G: High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer. Transplantation 101: 1295–1302, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Acuna SA, Huang JW, Scott AL, Micic S, Daly C, Brezden-Masley C, et al.: Cancer screening recommendations for solid organ transplant recipients: A systematic review of clinical practice guidelines. Am J Transplant 17: 103–114, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    James LJ, Wong G, Craig JC, Ju A, Williams N, Lim WH, et al.: Beliefs and attitudes to bowel cancer screening in patients with CKD: A semistructured interview study. Clin J Am Soc Nephrol 12: 568–576, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, et al.; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team: Colon cancer screening among patients receiving dialysis in the United States: Are we choosing wisely? J Am Soc Nephrol 28: 2521–2528, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Kitchlu A, Dixon S, Dirk JS, Chanchlani R, Vasilevska-Ristovska J, Borges K, et al.: Elevated risk of cancer after solid organ transplant in childhood: A population-based cohort study. Transplantation 103: 588–596, 2019 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Francis A, Johnson DW, Craig JC, Wong G: Incidence and predictors of cancer following kidney transplantation in childhood. Am J Transplant 17: 2650–2658, 2017 PubMed

  • 9.

    Bamoulid J, Courivaud C, Coaquette A, Crépin T, Carron C, Gaiffe E, et al.: Late persistent positive EBV viral load and risk of solid cancer in kidney transplant patients. Transplantation 101: 1473–1478, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Kitahara CM, Yanik EL, Ladenson PW, Hernandez BY, Lynch CF, Pawlish KS, et al.: Risk of thyroid cancer among solid organ transplant recipients. Am J Transplant 17: 2911–2921, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Laprise C, Cahoon EK, Lynch CF, Kahn AR, Copeland G, Gonsalves L, et al.: Risk of lip cancer after solid organ transplantation in the United States. Am J Transplant 19: 227–237, 2019 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Liu S, Chaudhry MR, Berrebi AA, Papadimitriou JC, Drachenberg CB, Haririan A, et al.: Polyomavirus replication and smoking are independent risk factors for bladder cancer after renal transplantation. Transplantation 101: 1488–1494, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Leung VKY, Dobbinson SJ, Goodman DJ, Kanellis J, Chong AH: Skin cancer history, sun-related attitudes, behaviour and sunburn among renal transplant recipients versus general population. Australas J Dermatol 59: e106–e113, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Rizvi SMH, Aagnes B, Holdaas H, Gude E, Boberg KM, Bjørtuft Ø, et al.: Long-term change in the risk of skin cancer after organ transplantation: A population-based nationwide cohort study. JAMA Dermatol 153: 1270–1277, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Stapleton CP, Birdwell KA, McKnight AJ, Maxwell AP, Mark PB, Sanders ML, et al.: Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort. Am J Transplant 19: 801–810, 2019 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Kang W, Sampaio MS, Huang E, Bunnapradist S: Association of pretransplant skin cancer with posttransplant malignancy, graft failure and death in kidney transplant recipients. Transplantation 101: 1303–1309, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Batabyal P, Chapman JR, Wong G, Craig JC, Tong A: Clinical practice guidelines on wait-listing for kidney transplantation: Consistent and equitable? Transplantation 94: 703–713, 2012 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Nguyen KA, Syed JS, Luciano R, Shuch B, Vourganti S: Optimizing waiting duration for renal transplants in the setting of renal malignancy: Is 2 years too long to wait? Nephrol Dial Transplant 32: 1767–1773, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Ying T, Wong G, Lim W, Kanellis J, Pilmore H, Campbell S, et al.: De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study. Am J Transplant 18: 2977–2986, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, et al.; TUMORAPA Study Group: Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results. J Clin Oncol 36: 2612–2620, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 35 21 1
Full Text Views 67 28 2
PDF Downloads 114 44 4